These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10093080)

  • 1. Preparation and properties of 99Tcm-exametazime using stannous ion augmentation of fractionated cold kits.
    Baker RJ
    Nucl Med Commun; 1999 Mar; 20(3):287-93. PubMed ID: 10093080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazime.
    Millar AM
    Nucl Med Commun; 1992 May; 13(5):306-11. PubMed ID: 1318530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven-hour stabilization of 99Tcm-exametazime (HMPAO) for cerebral perfusion.
    Solanki C; Wraight EP; Barber RW; Sampson CB
    Nucl Med Commun; 1998 Jun; 19(6):567-72. PubMed ID: 10234661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of generator eluate age on the radiochemical purity of fractionated 99Tcm-MAG3.
    Hung JC; Thorson LM
    Nucl Med Commun; 1995 Mar; 16(3):157-60. PubMed ID: 7770239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
    Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the synthesis, isolation, and radiochemical studies for the preparation of in-house kits for 99mTc-meso- and d,l-HMPAO: a few additional observations.
    Banerjee S; Samuel G; Kothari K; Sarma HD; Pillai MR
    Nucl Med Biol; 1999 Apr; 26(3):327-38. PubMed ID: 10363805
    [No Abstract]   [Full Text] [Related]  

  • 8. Stabilization and multidose use of exametazime for cerebral perfusion studies.
    Solanki C; Li DJ; Wong A; Barber RW; Wraight EP; Sampson CB
    Nucl Med Commun; 1994 Sep; 15(9):718-22. PubMed ID: 7816385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidose use of exametazine for leukocyte labelling: a new approach using tin enhancement.
    Solanki C; Li DJ; Wong A; Miles KA; Sampson CB
    Nucl Med Commun; 1993 Nov; 14(11):1035-40. PubMed ID: 8290160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of generator eluate on the radiochemical purity of 99Tcm-sestamibi prepared using fractionated Cardiolite kits.
    Varelis P; Parkes SL; Poot MT
    Nucl Med Commun; 1998 Jul; 19(7):615-23. PubMed ID: 9853341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term stability of reconstituted exametazime: a clinical and laboratory evaluation.
    Hawkins T; Reeder A; Keavey PM; Thakker S; Hawker R
    Nucl Med Commun; 1991 Dec; 12(12):1045-55. PubMed ID: 1811199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m labeling of a molecule bearing easily reducible groups.
    Tsopelas C
    Nucl Med Biol; 2000 Nov; 27(8):797-802. PubMed ID: 11150713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved (99m)Tc-aprotinin kit formulation: quality control analysis of radiotracer stability and cold kit shelf life.
    Smyth DR; Tsopelas C
    Nucl Med Biol; 2005 Nov; 32(8):885-9. PubMed ID: 16253814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
    Lerthirunwong C; Cheng KT; Hladik WB
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99Tcm-exametazime-labelled leucocytes: effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling.
    Sampson CB; Solanki C; Barber RW
    Nucl Med Commun; 1991 Aug; 12(8):719-23. PubMed ID: 1780111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Sn(II) in technetium cold kits by voltammetry at the hanging mercury drop electrode (HMDE) and relevant radiopharmaceutical applications.
    Decristoforo C; Obendorf D; Reichart E; Stubauer G; Riccabona G
    Nucl Med Biol; 1998 Oct; 25(7):675-83. PubMed ID: 9804049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pertechnetate source and age on the radiochemical purity of technetium Tc 99m exametazime.
    Ponto JA
    Am J Hosp Pharm; 1990 Nov; 47(11):2511-3. PubMed ID: 2177584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.